By Mark Hobraczk, JD, MPA
House and Senate bills would limit prescription drug cost-sharing
House and Senate measures that would limit consumer cost-sharing for prescription drugs have been reintroduced in the special legislative session that started earlier this month.
The bills (H.B. 2602 and S.B. 6320) would each cap the copayment, coinsurance, or other costsharing at $100 for a 30-day supply of an individual prescription drug, starting January 1st. For nongrandfathered individual or small group plans, the annual deductible for outpatient drugs all could not exceed $500. Each measure would allow for inflationary increases in these limits.
Both bills were previously introduced during the regular session but failed to advance (see Specialty Tier Reform Update for Week of February 1st).